RE: Gout and sodium-glucose cotransporter-2 inhibitors

Affiliations

¹ Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
² Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark.

Comment

Lars Christian Lund et al. Pharmacoepidemiol Drug Saf. 2022 Jan.

. 2022 Jan;31(1):114-115.

doi: 10.1002/pds.5380. Epub 2021 Nov 14.

¹ Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
² Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark.

No abstract available

Comment on

Sodium-glucose cotransporter-2 inhibitors and the risk of gout: A Danish population based cohort study and symmetry analysis.
Lund LC, Højlund M, Henriksen DP, Hallas J, Kristensen KB. Lund LC, et al. Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1391-1395. doi: 10.1002/pds.5252. Epub 2021 May 13. Pharmacoepidemiol Drug Saf. 2021. PMID: 33881179
Gout and sodium-glucose cotransporter-2 inhibitors.
Lai SW. Lai SW. Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):112-113. doi: 10.1002/pds.5373. Epub 2021 Nov 14. Pharmacoepidemiol Drug Saf. 2022. PMID: 34668261 No abstract available.